Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown symbols : NVO save search
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published: 2023-06-22 (Crawled : 14:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
fda pancreas clearance insulin
Oak Hill Bio Announces Formation of Board of Directors
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.07%
H: 0.47%
C: -0.4%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -3.41%
H: 1.22%
C: 0.49%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
PathAI and Novo Nordisk present AI-powered scoring showing significant reduction of fibrosis following semaglutide treatment in patients with NASH
Published: 2021-11-10 (Crawled : 17:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.9%
H: 0.32%
C: -0.81%
treatment ema fibrosis nash
Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021
Published: 2021-11-04 (Crawled : 18:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.06%
H: 0.26%
C: 0.19%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 3.16%
H: 0.0%
C: 0.0%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.24%
H: 7.69%
C: 7.59%
kidney
Dicerna Reports Positive Top-Line Results From PHYOX™2 Pivotal Clinical Trial of Nedosiran for the Treatment of Primary Hyperoxaluria
Published: 2021-08-05 (Crawled : 21:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 3.16%
H: 1.88%
C: 1.77%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.31%
H: 0.85%
C: 0.35%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.2%
H: 5.7%
C: 5.5%
treatment positive results trial topline
Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.4%
H: 0.3%
C: -0.88%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.01%
H: 1.3%
C: -0.14%
new drug alcohol use disorder fda clearance treatment fda drug application clearance
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-06-22 (Crawled : 12:15) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.39%
H: 0.27%
C: -0.21%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.02%
H: 0.44%
C: -0.53%
ALNY | News | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.08%
H: 1.01%
C: 0.9%
disease liver disease treatment phase 2 liver trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.